Do Kymera Therapeutics Inc (NASDAQ: KYMR) Fit In A Value Investing Philosophy?
Currently, there are 55.59M common shares owned by the public and among those 54.60M shares have been available to trade. The company’s stock has a 5-day price change of -9.75% and -21.15% over the past three months. KYMR shares are trading 22.55% year to date (YTD), with the 12-month market performance up to 20.65% higher. […]
